Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / RDH11

RDH11

Basics

Aliases:
This biomarker is also known as:
  • retinol dehydrogenase 11 (all-trans and 9-cis),
  • retinal reductase 1,
  • MDT1,
  • HCBP12,
  • Androgen-regulated short-chain dehydrogenase/reductase 1,
  • androgen-regulated short-chain dehydrogenase/reductase 1,
  • Retinal reductase 1,
  • ARSDR1,
  • EC 1.1.1.300,
  • PSDR1,
  • CGI82,
  • SDR7C1,
  • retinol dehydrogenase 11 (all-trans/9-cis/11-cis),
  • RalR1,
  • short chain dehydrogenase/reductase family 7C, member 1,
  • retinol dehydrogenase 11,
  • RALR1,
  • SCALD,
  • Prostate short-chain dehydrogenase/reductase 1,
  • prostate short-chain dehydrogenase/reductase 1,
  • prostate short-chain dehydrogenase reductase 1,
  • HCV core-binding protein HCBP12,

View in BioMuta

Description…

retinol dehydrogenase 11 (all-trans/9-cis/11-cis)

Attributes

QA State: Under Review
Type: Gene
Short Name:
HGNC Name: RDH11

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place October 15–16, 2015 in Bethesda, Maryland.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to http://grants.nih.gov /grants/guide/ pa-files/ PAR-15-289.html.

Announcement 04/08/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held October 15-16, 2015 on the NCI campus. More information will be available later this summer.